Novo Nordisk shares up on hopes for recovery of Wegovy weight-loss drug sales in U.S

Why is the US ending the Energy Star program? How will Trump's tariffs impact US automakers? What caused Apple's Safari search to decline? Why did WeightWatchers file for bankruptcy? How are US-China trade talks affecting markets? Why is Disney building a new park in Abu Dhabi? What risks does the Fed see from tariff policies? How did Bumble's revenue drop affect its stock? Why is Ford raising prices on Mexico-made cars?

Novo Nordisk shares up on hopes for recovery of Wegovy weight-loss drug sales in U.S

theglobeandmail.com/business/international-business/article-novo-nordisk-shares-up-on-hopes-for-recovery-of-wegovy-weight-loss

Drugmaker Novo Nordisk NVO-N expects a recovery of Wegovy weight-loss drug sales in the United States once a ban on compound copycats is enforced this month, its CEO said on Wednesday, boosting the shares.
Booming sales of Wegovy helped to make Novo the most valuable listed company in…

This story appeared on theglobeandmail.com, 2025-05-07 11:50:54.